Spatial Distribution of Underweight, Overweight and Obesity among Women and Children: Results from the 2011 Uganda Demographic and Health Survey

por Turi, Kedir N., Christoph, Mary J., Grigsby-Toussaint, Diana S.
Publicado 2013

Does non-standard work mean non-standard health? Exploring links between non-standard work schedules, health behavior, and well-being

por Winkler, Megan R., Mason, Susan, Laska, Melissa N., Christoph, Mary J., Neumark-Sztainer, Dianne
Publicado 2017

Derivation and validation of a composite scoring system (SAVED(2)) for prediction of unfavorable modified Rankin scale score following intracerebral hemorrhage

por Coleman, Craig I., Concha, Mauricio, Koch, Bruce, Lovelace, Belinda, Christoph, Mary J., Cohen, Alexander T.
Publicado 2023

Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor‐associated major bleeding: A real‐world analysis of Medicare beneficiaries

por Williams, James M., Lovelace, Belinda, Christoph, Mary J., Li, Suying, Guo, Haifeng, Hoover, Madison, Coleman, Craig I.
Publicado 2023

Real-world clinical outcomes among US Veterans with oral factor xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate

por Sutton, S. Scott, Magagnoli, Joseph, Cummings, Tammy H., Dettling, Theresa, Lovelace, Belinda, Christoph, Mary J., Hardin, James W.
Publicado 2023

Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex conce...

por Sutton, S. Scott, Magagnoli, Joseph, Cummings, Tammy H., Dettling, Theresa, Lovelace, Belinda, Christoph, Mary J., Hardin, James W.
Publicado 2023

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weight...

por Costa, Olivia S., Connolly, Stuart J., Sharma, Mukul, Beyer-Westendorf, Jan, Christoph, Mary J., Lovelace, Belinda, Coleman, Craig I.
Publicado 2022

Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study

por Dobesh, Paul P., Fermann, Gregory J., Christoph, Mary J., Koch, Bruce, Lesén, Eva, Chen, Hungta, Lovelace, Belinda, Dettling, Theresa, Danese, Mark, Ulloa, Julie, Danese, Sherry, Coleman, Craig I.
Publicado 2023

Definition of factor Xa inhibitor–related, life‐threatening gastrointestinal bleeding and guidance on when to use reversal therapy: A Delphi panel

por Fermann, Gregory J., Cash, Brooks D., Coelho‐Prabhu, Nayantara, Maegele, Marc, Bingisser, Roland, Sehgal, Vinay, Cohen, Alexander T., Golden, Anna Hundt, Russo, Jon, Price, Mark, Mangel, Allen, Koch, Bruce, Christoph, Mary J., Milling, Truman J.
Publicado 2023